The clinical presentation of keratoconjunctivitis sicca (more commonly known as "dry eye") stems from an excessive evaporation of tears and/or their deficiency [1] [2]. This condition is a relatively frequent disorder in general practice, particularly in the elderly population, with the most common complaints being a burning, stinging, foreign body sensation, as well as pruritus and photophobia [1] [2] [3] [4]. Keratoconjunctivitis sicca has shown to significantly affect the quality of life due to its overall effect on vision [2] [5]. Driving could be problematic, reading speed is frequently markedly reduced, while looking at the computer screen can be quite disturbing and unpleasant [2] [5]. In fact, anxiety and depression were shown to be much more frequent among patients suffering from dry eyes compared to disease-free individuals [2] [5] [6]. Aside from present complaints, keratoconjunctivitis sicca predisposes individuals to numerous complications. Scarring, ulceration, and even perforation of the cornea, bacterial keratitis (an infection with the potential to cause blindness), post-procedural complications from eye surgeries, blepharitis, meibomitis, and conjunctival pathologies have all been reported [1] [2].

Because keratoconjunctivitis sicca may be a constitutive feature of a very large number of diseases, the physician should obtain a detailed patient history and conduct a thorough physical examination in order to determine the underlying etiology. The course of symptoms, their progression, as well as severity must be assessed, whereas the presence of any systemic disease (for example diabetes mellitus), history of drug use (postmenopausal estrogens, tricyclic antidepressants, diuretics, beta-blockers, antihistamines), and recent corneal surgery are some of the factors that might play a crucial role in the pathogenesis [1] [2] [7]. Sjogren's syndrome, however, is one of the most important causes of keratoconjunctivitis sicca and thus appropriate studies need to be carried out [2] [7]. After a detailed inspection of the eye (assessment of blinking rate and the lids being important components), a slit-lamp examination can solidify clinical suspicion [2]. Evaluation of eyelid margins, tear film, and meibomian glands, staining of the ocular surface (with fluorescein), and the Schirmer test are recommended studies [2]. On the other hand, appropriate laboratory studies are equally useful. Both anti-Ro (SSA) and anti-La (SSB) antibodies need to be measured to rule out Sjogren's syndrome and other autoimmune disorders as the cause [2].

Treatment for Keratoconjunctivitis Sicca aims to relieve symptoms and prevent damage to the eye's surface. Options include:

• Artificial Tears: Over-the-counter lubricating eye drops to supplement natural tears.
• Prescription Medications: Such as cyclosporine or lifitegrast, which reduce inflammation and increase tear production.
• Punctal Plugs: Small devices inserted into tear ducts to retain moisture on the eye's surface.
• Lifestyle Modifications: Including using humidifiers, taking breaks from screens, and wearing protective eyewear.

The prognosis for Keratoconjunctivitis Sicca varies. While it is a chronic condition, many patients find relief with appropriate treatment and lifestyle adjustments. Regular follow-up with an eye care professional is essential to manage symptoms and prevent complications.

Keratoconjunctivitis Sicca can result from various factors, including:

• Aging: Tear production naturally decreases with age.
• Medications: Certain drugs, like antihistamines and antidepressants, can reduce tear production.
• Medical Conditions: Autoimmune diseases such as Sjögren's syndrome, rheumatoid arthritis, and lupus.
• Environmental Factors: Prolonged exposure to dry or windy conditions.

Keratoconjunctivitis Sicca is a common condition, affecting millions worldwide. It is more prevalent in older adults and women, particularly postmenopausal women. The condition is also more common in individuals with autoimmune disorders.

The pathophysiology of Keratoconjunctivitis Sicca involves a disruption in the tear film, which consists of three layers: lipid, aqueous, and mucin. An imbalance in any of these layers can lead to tear film instability and increased evaporation, resulting in dry eye symptoms. Inflammation of the ocular surface and tear-producing glands further exacerbates the condition.

Preventing Keratoconjunctivitis Sicca involves minimizing risk factors and maintaining eye health. Strategies include:

• Regular Eye Exams: To detect early signs of dry eye.
• Hydration: Drinking plenty of water to support tear production.
• Environmental Control: Using humidifiers and avoiding smoke or wind exposure.
• Screen Breaks: Reducing screen time and taking frequent breaks to rest the eyes.

Keratoconjunctivitis Sicca, or Dry Eye Syndrome, is a prevalent condition characterized by inadequate tear production or poor tear quality. It can cause discomfort and visual disturbances but is manageable with appropriate treatment and lifestyle changes. Understanding the condition's causes and symptoms is crucial for effective management and prevention.

If you experience symptoms such as dry, itchy, or burning eyes, it may be due to Keratoconjunctivitis Sicca. This condition, also known as Dry Eye Syndrome, occurs when your eyes do not produce enough tears or the tears evaporate too quickly. It is important to seek advice from an eye care professional who can recommend treatments like artificial tears or lifestyle changes to help manage your symptoms and protect your eye health.

1. Javadi M-A, Feizi S. Dry Eye Syndrome. J Ophthalmic Vis Res. 2011;6(3):192-198.
2. Messmer EM. The Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease. Dtsch Arztebl Int. 2015;112(5):71-82.
3. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283–2292.
4. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjögren’s syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci. 1994;35:3493–3504.
5. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409–415.
6. Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799–806.
7. Whitcher JP. The treatment of dry eyes. Br J Ophthalmol. 2004;88(5):603-604.